Figure 4. Model validation: CD4⁺ cell counts/mm³ at three different time points (Baseline, Week 40 and Week 48).

In the upper panel we compare the median CD4⁺ cell counts of 250 virtual patients with the data of real patients from the continuous treatment arm of Dybul's clinical trial. In the lower panel we compare the median CD4⁺ cell counts of 250 virtual patients with the data of real patients from the STI arm of Dybul's clinical trial.